High-tech facility for pharmaceutical ingredients production will be built in Tumen

| By | Drug Manufacturing, Evalar

Tumen region and Evalar Company have signed an investment partnership agreement at the Russian Investment Forum in Sochi.

In the framework of cooperation with Tumen region Evalar considers the possibility to build there a high-tech facility for production of pharmaceutical ingredients and processing of raw material. Estimated project budget is about 3-4 bln rubles.

Vladimir Yakushev, Governor of Tumen region has pointed out that ‘the company has gained advanced expertise, profound research and production capacity’.

‘Active geographical expansion of federal supplies and facilitation of the export component (today we ship our produce to 24 countries all over the world) – bring up an issue of development of production facilities and business infrastructure. Construction of a high-tech production of pharmaceutical ingredients in Tumen will be our first step, as we deem it’, emphasized Larisa Prokopyeva, Director of Evalar Company.

According to Prokopyeva, construction of a logistics hub in the European part of Russia is another urgent task of the company. This will allow the company to decrease the workload of the sites in the Altai Krai and reduce costs when working with Europe.